Sonal Admane MD MPH

MASCC Short Talks: Dr. Eduardo Bruera This is "MASCC Short Talks: Dr. Eduardo Bruera" by MASCC on Vimeo, the home for high quality videos and the people who love them.

Our next MASCC Short Talk features @brueraeduardo.bsky.social discussing how we can best partner with patients in managing chronic toxicities of cancer and its treatment

Watch now: vimeo.com/1119840739

#MASCC25 #SuppOnc

From Emails to EMR: Implementing I-PASS Among Inpatient Palliative Care Clinicians at a Comprehensive Cancer Center-A Quality Improvement Initiative - PubMed I-PASS was fully adopted by the team, with nearly 100% utilization and strong clinician endorsement as an effective communication tool. Future efforts should focus on optimizing usability, particularl...

A palliative care team replaced email handoffs with EMR-integrated I-PASS. Within six months, utilization exceeded 99%, with clinicians reporting higher accuracy, shorter length, and less time required. I-PASS was strongly endorsed as an effective handoff tool.

pubmed.ncbi.nlm.nih.gov/40940972/

Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021 - PubMed During the study period, we observed a five-fold decline in opioid dose prescribed by oncologists for cancer pain. This raises concerns for undertreatment of pain in patients with cancer.

Between 2016–2021, opioid doses prescribed by oncologists for cancer pain dropped five-fold, despite guideline exemptions. Long acting decreased the most.Higher pain and CAGE-AID scores predicted higher doses; non-English speakers received lower doses.
pubmed.ncbi.nlm.nih.gov/40138614/

Kudos and gratitude to the organizers, attendees, and fellow faculty members for today's Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment #MASCC25
@maryamlustberg.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @brueraeduardo.bsky.social

Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021 - PubMed During the study period, we observed a five-fold decline in opioid dose prescribed by oncologists for cancer pain. This raises concerns for undertreatment of pain in patients with cancer.

pubmed.ncbi.nlm.nih.gov/40138614/

Circadian rhythm in end-of-life delirium: a secondary analysis of two randomized controlled trials : The circadian pattern of restlessness in end-of-life delirium is understudied and poorly understood.

Circadian rhythm in end-of-life delirium: a secondary analysis of two randomized controlled trials - Journal of Pain and Symptom Management www.jpsmjournal.com/article/S088... @brueraeduardo.bsky.social

Opioid prescription declines among cancer patients: What to know - Becker's Hospital Review | Healthcare News & Analysis Cancer patients experienced a fivefold decline in opioid dose prescriptions between 2016 and 2021, according to a study published March 26 in JCO Oncology Practice.  For the study, researchers from Ho...

www.beckershospitalreview.com/oncology/opi... #jcoop @brueraeduardo.bsky.social

Study Flags Potential Undertreatment of Cancer Pain The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

www.cancertherapyadvisor.com/news/study-f... @brueraeduardo.bsky.social @mdanderson.bsky.social #jcoop

Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021 | JCO Oncology Practice PURPOSEIncreasing opioid regulations have resulted in reduced opioid prescriptions, including for cancer pain, despite guideline exemptions. Data after 2017 following the Centers for Disease Control's...

Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021 | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Can conversational AI define end of life terms? We examine AI generated definitions in our latest paper @j-palliativemed.bsky.social #AI #Digitalhealth #palliativecare

Opioid prescriptions for cancer pain have plunged 5 fold from 2016-2021! Under the mentorship of @brueraeduardo.bsky.social we spotlight the shifting trends in cancer pain management. Now in #JCOOP #ASCO.